-
Signature
-
Sean D. Mersten, Attorney in Fact for Mark E. Delaney
-
Issuer symbol
-
DGX
-
Transactions as of
-
12 May 2025
-
Net transactions value
-
-$306,800
-
Form type
-
4
-
Filing time
-
14 May 2025, 17:12:30 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| DELANEY MARK E |
SVP & Chief Commercial Officer |
500 PLAZA DRIVE, C/O QUEST DIAGNOSTICS INC, SECAUCUS |
Sean D. Mersten, Attorney in Fact for Mark E. Delaney |
14 May 2025 |
0001955265 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
DGX |
Common Stock |
Sale |
$153,579 |
-874 |
-9.5% |
$175.72 |
8,372 |
12 May 2025 |
Direct |
F1 |
| transaction |
DGX |
Common Stock |
Sale |
$153,221 |
-874 |
-10% |
$175.31 |
7,498 |
13 May 2025 |
Direct |
F1 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: